Vertex Pharmaceuticals, Inc. (VRTX)
441.36
+2.44
(+0.56%)
USD |
NASDAQ |
Jan 16, 16:00
440.02
-1.34
(-0.30%)
After-Hours: 20:00
Vertex Pharmaceuticals Market Cap: 111.98B for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 145.84B |
| Amgen, Inc. | 177.92B |
| Eli Lilly & Co. | 929.39B |
| Merck & Co., Inc. | 270.12B |
| Alnylam Pharmaceuticals, Inc. | 47.46B |
Market Cap Related Metrics
| PE Ratio | 31.11 |
| PS Ratio | 9.746 |
| Price to Book Value | 6.466 |
| Price to Free Cash Flow | 34.27 |
| Price | 441.36 |
| Earnings Yield | 3.21% |
| Operating PE Ratio | 25.26 |
| Normalized PE Ratio | 28.21 |